A detailed history of Geode Capital Management, LLC transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 188,173 shares of TKNO stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
188,173
Previous 151,259 24.4%
Holding current value
$1.5 Million
Previous $207,000 339.61%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.2 - $5.17 $44,296 - $190,845
36,914 Added 24.4%
188,173 $910,000
Q2 2024

Aug 09, 2024

BUY
$1.29 - $2.81 $3,655 - $7,963
2,834 Added 1.91%
151,259 $207,000
Q1 2024

May 13, 2024

BUY
$2.41 - $3.88 $6,133 - $9,874
2,545 Added 1.74%
148,425 $393,000
Q4 2023

Feb 13, 2024

BUY
$1.85 - $3.73 $133,170 - $268,500
71,984 Added 97.41%
145,880 $544,000
Q3 2023

Nov 13, 2023

BUY
$1.66 - $3.83 $8,766 - $20,226
5,281 Added 7.7%
73,896 $206,000
Q2 2023

Aug 11, 2023

SELL
$1.8 - $3.98 $103,422 - $228,678
-57,457 Reduced 45.57%
68,615 $183,000
Q1 2023

May 15, 2023

BUY
$2.74 - $6.25 $46 - $106
17 Added 0.01%
126,072 $373,000
Q4 2022

Feb 13, 2023

BUY
$3.23 - $5.64 $8,375 - $14,624
2,593 Added 2.1%
126,055 $710,000
Q3 2022

Nov 14, 2022

SELL
$3.34 - $9.2 $367 - $1,011
-110 Reduced 0.09%
123,462 $412,000
Q2 2022

Aug 12, 2022

SELL
$6.39 - $16.24 $9,067 - $23,044
-1,419 Reduced 1.14%
123,572 $1.04 Million
Q1 2022

May 13, 2022

BUY
$12.79 - $21.64 $73,900 - $125,035
5,778 Added 4.85%
124,991 $1.73 Million
Q4 2021

Feb 11, 2022

BUY
$17.49 - $26.72 $677,387 - $1.03 Million
38,730 Added 48.12%
119,213 $2.44 Million
Q3 2021

Nov 12, 2021

BUY
$17.47 - $27.49 $1.41 Million - $2.21 Million
80,483 New
80,483 $2 Million

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $224M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.